Human RAGE Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDRG00
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (50 µL), Serum (50 µL), EDTA Plasma (50 µL), Heparin Plasma (50 µL)
• Sensitivity: 16.14 pg/mL
• Range: 78 - 5,000 pg/mL (Serum, Heparin Plasma, Cell Culture Supernates, EDTA Plasma)
• Format: 96-well strip plate
• Description: The Quantikine Human RAGE Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human RAGE (extracellular domain) in cell culture supernates, serum, and plasma
• Gene: AGER

Product References

The impact of concomitant pulmonary infection on immune dysregulation in - The impact of concomitant pulmonary infection on immune dysregulation in

Chou CW, Lin FC, Tsai HC, Chang SC. BMC Pulm Med. 2014 Nov 19;14:182.

Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated - Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated

Hong S, Zhang X, Chen J, Zhou J, Zheng Y, Xu C. J Ovarian Res. 2013 Nov 20;6(1):80.

Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor - Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor

Zakiyanov O, Kriha V, Vachek J, Zima T, Tesar V, Kalousova M. BMC Nephrol. 2013 Nov 4;14:245.

Soluble RAGE as a severity marker in community acquired pneumonia associated - Soluble RAGE as a severity marker in community acquired pneumonia associated

Narvaez-Rivera RM, Rendon A, Salinas-Carmona MC, Rosas-Taraco AG. BMC Infect Dis. 2012 Jan 20;12:15.

Methodological and preanalytical evaluation of a RAGE immunoassay. - Methodological and preanalytical evaluation of a RAGE immunoassay.

Wittwer C, Lehner J, Fersching D, Siegele B, Stoetzer OJ, Holdenrieder S. Anticancer Res. 2012 May;32(5):2075-8.

Diastolic dysfunction of aging is independent of myocardial structure but - Diastolic dysfunction of aging is independent of myocardial structure but

Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, Kenny JF, Newcomb AE, Schalkwijk CG, Black MJ, Kelly DJ. PLoS One. 2012;7(11):e49813.

The soluble form of the receptor of advanced glycation endproducts increases - The soluble form of the receptor of advanced glycation endproducts increases

Brix JM, Hollerl F, Kopp HP, Schernthaner GH, Schernthaner G. Int J Obes (Lond). 2012 Nov;36(11):1412-7.

Soluble form of the receptor for advanced glycation end products is a marker of - Soluble form of the receptor for advanced glycation end products is a marker of

Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, Mrozek S, Perbet S, Cayot-Constantin S, Chartier C, Sapin V, Bazin JE, Constantin JM. Crit Care Med. 2011 Mar;39(3):480-8.

Total soluble and endogenous secretory receptor for advanced glycation end - Total soluble and endogenous secretory receptor for advanced glycation end

Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, Charlton-Menys V, Bao W, Demicco DA, Preston GM, Deshmukh H, Tan K, Fuller JH. Diabetes. 2011 Sep;60(9):2379-85.

Proteolytic release of the receptor for advanced glycation end products from in - Proteolytic release of the receptor for advanced glycation end products from in

Yamakawa N, Uchida T, Matthay MA, Makita K. Am J Physiol Lung Cell Mol Physiol. 2011 Apr;300(4):L516-25. doi: